Skip to main content

Table 4 Association between genotypes of MMP and colorectal adenomas

From: Genetic polymorphisms of MMP1, MMP3 and MMP7gene promoter and risk of colorectal adenoma

 

Large adenoma patients (LA)

Polyp free controls (PF)

Small adenoma patients (SA)

LA vs PF

 

LA vs SA

 

SA vs PF

 
    

OR* (95%CI)

P**

OR* (95%CI)

P**

OR* (95%CI)

P**

MMP1

         

1G/1G

81

154

81

1

 

1

 

1

 

1G/2G

139

285

139

0.94 (0.66–1.33)

 

1.04 (0.69–1.56)

 

0.96 (0.67–1.37)

 

2G/2G

72

122

79

1.18 (0.78–1.78)

0.491

0.90 (0.56–1.43)

0.792

1.22 (0.81–1.84)

0.431

MMP3.1

         

5A/5A

70

130

68

1

 

1

 

1

 

5A/6A

139

291

132

0.87 (0.60–1.25)

 

1.10 (0.72–1.69)

 

0.85 (0.58–1.24)

 

6A/6A

73

126

93

1.11 (0.73–1.69)

0.391

0.78 (0.48–1.25)

0.250

1.50 (0.99–2.28)

0.008

MMP3.2

         

AA

182

358

194

1

 

1

 

1

 

AG

105

187

92

1.10 (0.81–1.50)

 

1.20 (0.83–1.73)

 

0.87 (0.64–1.20)

 

GG

7

19

16

0.72 (0.29–1.78)

0.615

0.49 (0.19–1.27)

0.175

1.34 (0.65–2.75)

0.464

MMP7

         

AA

92

187

99

1

 

1

 

1

 

AG

138

259

136

1.08 (0.77–1.50)

 

1.06 (0.72–1.56)

 

0.98 (0.70–1.38)

 

GG

64

119

67

1.17 (0.78–1.77)

0.742

1.08 (0.67–1.72)

0.944

1.14 (0.76–1.71)

0.746

  1. * OR adjusted on age, sex, and group of centres
  2. ** P: p-value for the Wald test assessing the global effect of SNP, uncorrected for multiple testing